Sonophoresis-mediated permeation and retention of peptide dendrimers across human epidermis

Skin Research and Technology

Volumn 18, Issue 1, 2012, Pages 101-107

  Mutalik, Srinivas ^a   Nayak, Usha Y ^a   Kalra, Rohit ^a   Kumar, Aravind ^a   Kulkarni, Raghavendra V ^b   Parekh, Harendra S ^c  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b BLDE University Campus   (India)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Dendrimers; Skin permeation; Sonophoresis; Transdermal; Ultrasound

Indexed keywords

DENDRIMER GENERATION; DIFFUSION CELLS; HIGH CONCENTRATION; HUMAN EPIDERMIS; HUMAN SKIN; IN-VITRO; LOW MOLECULAR WEIGHT; PASSIVE DIFFUSIONS; PEPTIDE DENDRIMERS; PERMEATION RATE; POSITIVE CHARGES; SKIN PERMEATION; SOLID PHASE PEPTIDE SYNTHESIS; SONOPHORESIS; TRANSDERMAL; VERTICAL-TYPE;

ARGININE; PEPTIDES; PH EFFECTS; ULTRASONICS;

DENDRIMERS;

ARGININE; DENDRIMER; HISTIDINE; PEPTIDE DENDRIMER; UNCLASSIFIED DRUG;

ARTICLE; EPIDERMIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MEMBRANE TRANSPORT; MOLECULAR WEIGHT; PEPTIDE SYNTHESIS; PH; SONOPHORESIS; ULTRASOUND;

ABSORPTION; DENDRIMERS; ELECTROPHORESIS; HIGH-ENERGY SHOCK WAVES; HUMANS; PEPTIDES; RADIATION DOSAGE; SKIN ABSORPTION; SONICATION;

EID: 83655192122     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2011.00539.x     Document Type: Article

References (24)

1. Tomalia DA, Baker H, Dewald J, Hall MGK, Martin S, Roeck J, Ryder J, Smith P.A new class of polymers: starburst-dendritic macromolecules. Polym J 1985; 17: 117-132.
2. Gajbhiye V, Palanirajan VK, Tekade RK, Jain NK.Dendrimers as therapeutic agents: a systematic review. J Pharm Pharmacol 2009; 61: 989-1003.
3. Robinson JR, Lee VHL.Controlled drug delivery fundamentals and applications. New York: Marcel Dekker Inc., 1987.
4. Wang Z, Itoh Z, Hosaka Y, Kobayashi I, Nakano Y, Maeda I, Umeda F, Yamakawa J, Kawase M, Yag K.Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer. J Biosci Bioeng 2003; 95: 541-543.
5. Chauhan AS, Sridevi S, Chalasani KB, Jain AK, Jain SK, Jain NK, Diwan PV.Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release 2003; 90: 335-343.
6. Yiyun C, Na M, Tongwen X, Rongqiang F, Xueyuan W, Xiaomin W, Longping W.Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J Pharm Sci 2007; 3: 595-602.
7. Venuganti VV, Perumal OP.Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int J Pharm 2008; 361: 230-238.
8. Borowska K, Laskowska B, Magoń A, Mysliwiec B, Pyda M, Wolowiec S.PAMAM dendrimers as solubilizers and hosts for 8-methoxypsoralene enabling transdermal diffusion of the guest. Int J Pharm 2010; 398: 185-189.
9. Parekh HS. The advance of dendrimers - a versatile targeting platform for gene/drug delivery. Curr Pharm Des 2007; 27: 2837-2850.
10. Niederhafner P, Sebestik J, Jezek J.Peptide dendrimers. J Pept Sci 2005; 11: 757-788.
11. Cloninger MJ. Biological applications of dendrimers. Curr Opin Chem Biol 2002; 6: 742-748.
12. Sebestik J, Niederhafner P, Jezek J.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications. Amino Acids 2011; 40: 301-370.
13. Luo K, Li C, Wang G, Nie Y, He B, Wu Y, Gu Z.Peptide dendrimers as efficient and biocompatible gene delivery vectors: synthesis and in vitro characterization. J Control Release 2010 (in press); doi: DOI: 10.1016/j.jconrel.2010.10.006.
14. Mutalik S, Hewavitharana AK, Shawa PN, Anissimov YG, Roberts MS, Parekh HS.Development and validation of a reversed-phase high-performance liquid chromatographic method for quantification of peptide dendrimers in human skin permeation experiments. J Chromatogr B 2009; 877: 3556-3562.
15. Kost J, Mitragotri S, Langer R.Phonophoresis. In: Bronaugh RL, Maibach HI, eds. Percutaneous absorption, 3rd edn. Boca Raton: Taylor and Francis, 1999: 615-631.
16. Alvarez-Román R, Merino G, Kalia YN, Naik A, Guy RH.Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. J Pharm Sci 2003; 6: 1138-1146.
17. Merino G, Kalia YN, Delgado-Charro MB, Potts RO, Guy RH.Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J Control Release 2003; 88: 85-94.
18. Mitragotri S, Kost J.Low-frequency sonophoresis: a review. Adv Drug Deliv Rev 2004; 5: 589-601.
19. Mutalik S, Parekh HS, Davies NM, Udupa N.A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug Del 2009; 16: 82-91.
20. Parekh HS, Marano RJ, Rakoczy EP, Blanchfield J, Toth I.Synthesis of a library of polycationic lipid core dendrimers and their evaluation in the delivery of an oligonucleotide with hVEGF inhibition. Bioorg Med Chem 2006; 14: 4775-4780.
21. Lai PM, Anissimov YG, Roberts MS.Lateral iontophoretic solute transport in skin. Pharm Res 1999; 1: 46-54.
22. Tezel A, Sens A, Tuchscherer J, Mitragotri S.Synergistic effect of low-frequency ultrasound and surfactants on skin permeability. J Pharm Sci 2002; 1: 91-100.
23. Polat BE, Blankschtein D, Langer R.Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert Opin Drug Deliv 2010; 7: 1415-1432.
24. Polat BE, Hart D, Langer R, Blankschtein D.Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release 2011, doi: DOI: 10.1016/j.jconrel.2010.10.006.